对于联合化疗,美国胸科医师学会(ACCP)建议4个周期的铂类药物联合依托泊苷(PE)。[29]对接受化疗和放疗的患者,国家综合癌症网络(NCCN)指南建议最多4-6个周期的顺铂和依托泊苷。[25]在绝大多数随机化对照试验中,超过4-6个周期的继续化疗未显示出总体生存期的显著改善,并已相当大的毒性增加相关联;事实上,许多肿瘤...
美国癌症联合委员会(American Joint Commission for Cancer, AJCC)2010年采用了新的TNM分期系统。[26]此外,2011年美国国家综合癌症网络(National Comprehensive Cancer Network, NCCN)的SCLC临床实践指南将TNM分期纳入其诊断和治疗的算法中; NCCN建议研究人员开始使用TNM分期系统,以努力更准确地评估预后和更具体地个性化治疗...
NCCN Guidelines Version 2.2013 Panel Members Small Cell Lung Cancer NCCN Guidelines Index SCLC Table of Contents Discussion *Gregory P. Kalemkerian, MD/Chair † University of Michigan Comprehensive Cancer Center Wallace Akerley, MD † Huntsman Cancer Institute at the University of Utah Paul Bogner...
SCLC is further divided into two categories: oats-cell cancer [bronchial epithelial cells develop a hostile malignancy neuroendocrine (NE) tumor] and cSCLC (combined small-cell lung cancer and nonsmall cell lung cancer). 2.1.1 Oats-Cell Carcinoma When viewed under a microscope, these cancer...
NCCN Guidelines Version 2.2013 Updates Non-Small Cell Lung Cancer NCCN Guidelines Index NSCLC Table of Contents Discussion Updates in the 1.2013 version of the Guidelines for Non-Small Cell Lung Cancer from the 3.2012 version include: NSCL-5 (continued) · Footnote "r": Rusch VW, Giroux DJ, ...
Small cell lung cancerSEERCHEMOTHERAPYSURVIVALRESECTIONRADIOTHERAPYCARCINOMAPurpose The NCCN guidelines do not recommend surgery for T3-4N0M0/T1-4N1-2M0 small cell lung cancer (SCLC) due to a lack of evidence.Methods Data of patients with T3-4N0M0/T1-4N1-2M0 SCLC were extracted from the ...
Small cell lung cancer (SCLC), previously known as oat cell carcinoma, is considered distinct from other lung cancers, which are called non–small cell lung cancers (NSCLCs) because of their clinical and biologic characteristics. See the image below.
原发性肺癌是我国最常见的恶性肿瘤。从病理和治疗角度,肺癌大致可以分为非小细胞肺癌(non small cell lung cancer,NSCLC)和小细胞肺癌(small cell lung cancer,SCLC)两大类,其中非小细胞肺癌约占80%～85%,包括腺癌、鳞癌等组织学亚型,其余为小细胞肺癌。腺癌的比例最高,占NSCLC的50%。在非小细胞肺癌中,约50%...
[3] National Comprehensive Cancer Network. NCCN clinical practice guidelines in Oncology:Small Cell Lung Cancer (2024. V2) [EB/OL]. [2024-05-14]. SmallCellLungCancer_2024.V2_EN.pdf [4] KHURSHID H, ISMAILA N, BIAN J, et al. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario ...
NCCN Clinical Practice Guidelines in Oncology: Nonsmall Cell Lung Cancer, V. 2.2010 Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. P... DS Ettinger,W Akerley,H Borghaei,... - 《Journa...